Neuropace, Inc. - Common Stock — 재무제표 (NASDAQ:NPCE) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 133.56 M114.11 M107.65 M94.65 M105.56 M 총 부채 60.06 M79.33 M87 M86.63 M86.53 M 자본금 총액 73.5 M34.78 M20.65 M8.01 M19.03 M 총 부채 및 주주자본 133.56 M114.11 M107.65 M94.65 M105.56 M 총부채 49.85 M52.91 M56.95 M59.52 M58.88 M 순부채 -65.75 M-24.49 M-9.55 M6.72 M-2.22 M

뉴스

Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?

NPCE Explains How NeuroPace's RNS System Makes Money

NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care

NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised

NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript

NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates

BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?

NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?

Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026

NPCE RNS System Explained: Growth Drivers and Setup for 2026

NeuroPace's Seizure ID and New Indication Could Expand RNS Demand

뉴로페이스(NPCE) 최고 의료 책임자, 39만 9천 달러 상당의 주식 매도